PXI Auto Components
301560
Shenzhen Crastal Technology
300824
Shenzhen Zesum Technology
301486
4
Hanjia Design Group
300746
5
Harbin Jiuzhou Group
300040
CN Stock MarketDetailed Quotes
688658 Youcare Pharmaceutical Group
- 17.17
- +0.08+0.47%
Market Closed Apr 25 15:00 CST
7.73BMarket Cap62.44P/E (TTM)
17.31High16.42Low160.47KlotVolume17.28Open17.09Pre Close270.01MTurnover3.57%Turnover Ratio62.44P/E (Static)450.00MShares25.3552wk High2.16P/B7.73BFloat Cap11.9052wk Low20.51Limit Up450.00MShs Float34.23Historical High13.67Limit Down5.21%Amplitude11.79Historical Low--Dividend TTM16.83Avg Price86.54KlotAsk--Div YieldTTM100Lot Size68.34KlotBid
Youcare Pharmaceutical Group Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -9.97%4.26B | -10.92%3.22B | -16.11%2.14B | -11.11%1.08B | 5.05%4.73B | 10.61%3.62B | 24.50%2.55B | 14.51%1.21B | -12.51%4.5B | -10.72%3.27B |
| Refunds of taxes and levies | -26.26%25.75M | 31.82%21.97M | -79.24%3.42M | -99.96%6.04K | 36.91%34.92M | 7.63%16.67M | 14.15%16.46M | 307.32%13.87M | 450.77%25.51M | 234.39%15.49M |
| Cash received relating to other operating activities | -30.36%77.17M | 78.28%84.73M | 36.62%46.42M | 10.50%24.24M | 23.29%110.82M | 48.22%47.53M | 36.54%33.98M | -44.81%21.93M | 16.13%89.88M | -13.27%32.06M |
| Cash inflows from operating activities | -10.55%4.36B | -9.58%3.33B | -15.82%2.19B | -11.72%1.1B | 5.58%4.88B | 10.96%3.68B | 24.57%2.6B | 13.27%1.25B | -11.68%4.62B | -10.44%3.32B |
| Goods services cash paid | -15.77%1.22B | -7.99%942.67M | -5.00%606.57M | -10.41%315.67M | -9.83%1.45B | 4.27%1.02B | -7.90%638.48M | 3.25%352.33M | 13.47%1.61B | -4.56%982.59M |
| Staff behalf paid | 1.85%455.92M | -2.68%338.11M | -1.90%233.78M | -6.60%121.32M | 3.07%447.64M | 5.08%347.42M | 6.53%238.3M | 11.69%129.89M | 36.60%434.3M | 35.09%330.63M |
| All taxes paid | 0.05%393.26M | 0.16%276.39M | 4.11%195.32M | -19.63%94.87M | -23.17%393.05M | -18.97%275.94M | -12.56%187.6M | 3.65%118.04M | -1.07%511.6M | -6.24%340.56M |
| Cash paid relating to other operating activities | 2.95%1.85B | -12.78%1.34B | -13.04%909.79M | -1.52%421.91M | -17.65%1.8B | -8.60%1.54B | -3.28%1.05B | -23.69%428.42M | -11.22%2.19B | -5.62%1.68B |
| Cash outflows from operating activities | -4.08%3.92B | -9.01%2.9B | -7.83%1.95B | -7.28%953.76M | -13.69%4.09B | -4.51%3.18B | -4.64%2.11B | -9.19%1.03B | 0.54%4.74B | -2.45%3.33B |
| Net cash flows from operating activities | -44.21%438.24M | -13.19%430.49M | -50.43%241.51M | -32.73%146.13M | 748.26%785.49M | 2,865.24%495.89M | 481.38%487.23M | 760.06%217.24M | -123.52%-121.17M | -106.30%-17.93M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -73.68%100M | ---- |
| Cash received from returns on investments | --222.28K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -62.85%1.36M | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -74.67%626.75K | -30.60%1.32M | -71.74%467.75K | -92.41%124.8K | 4,217.74%2.47M | 2,866.38%1.9M | 2,673.35%1.66M | 2,685.52%1.64M | -19.30%57.3K | 126.16%63.89K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | --8.46M | --8.46M | --5.07M | ---- | ---- | ---- |
| Cash inflows from investing activities | -92.23%849.04K | -87.29%1.32M | -93.04%467.75K | -92.41%124.8K | -89.22%10.93M | 16,102.83%10.35M | 11,165.30%6.72M | 2,685.52%1.64M | -73.76%101.42M | -99.96%63.89K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -27.92%358.6M | -37.33%258.42M | -28.81%182.68M | -14.02%90.96M | -9.21%497.48M | 2.07%412.38M | -12.09%256.61M | -39.42%105.8M | 173.32%547.96M | 335.41%404.03M |
| Cash paid to acquire investments | 1,029.03%175M | 306.49%63.01M | -35.48%10M | ---- | -84.50%15.5M | -85.91%15.5M | -84.50%15.5M | --15M | -73.68%100M | -54.17%110M |
| Net cash paid to acquire subsidiaries and other business units | --3.01M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 46.32%10M | ---- |
| Cash paid relating to other investing activities | --10M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 6.56%546.61M | -24.88%321.43M | -29.19%192.68M | -24.70%90.96M | -22.04%512.98M | -16.76%427.88M | -30.57%272.11M | -30.83%120.8M | 12.03%657.96M | 51.35%514.03M |
| Net cash flows from investing activities | -8.71%-545.76M | 23.33%-320.11M | 27.57%-192.21M | 23.77%-90.84M | 9.79%-502.05M | 18.76%-417.53M | 32.27%-265.39M | 31.75%-119.16M | -177.11%-556.54M | -195.63%-513.97M |
| Financing cash flow | ||||||||||
| Cash from borrowing | 67.58%649.01M | 132.85%457.67M | 510.06%317.23M | --281.73M | 69.74%387.29M | 78.69%196.56M | --52M | ---- | 2,435.20%228.17M | 1,122.22%110M |
| Cash received relating to other financing activities | ---- | -56.00%66M | -56.00%66M | ---- | ---- | --150M | --150M | ---- | ---- | ---- |
| Cash inflows from financing activities | 67.58%649.01M | 51.11%523.67M | 89.72%383.23M | --281.73M | 69.74%387.29M | 215.05%346.56M | --202M | ---- | 2,435.20%228.17M | 1,122.22%110M |
| Borrowing repayment | 106.16%510.44M | 36.63%218.62M | 86.75%94.85M | --63M | 2,651.11%247.6M | 1,677.78%160M | 464.35%50.79M | ---- | -94.38%9M | -94.38%9M |
| Dividend interest payment | -77.98%111.25M | -79.39%103.84M | -80.23%99.05M | 201.09%4.44M | 64.01%505.12M | 64.34%503.78M | 579,156.31%501.13M | 1,603.51%1.47M | 50.28%307.98M | 49.81%306.54M |
| Cash payments relating to other financing activities | -16.45%55.78M | 750.50%204.47M | 2,745.27%201.4M | 621.68%25.03M | 421.89%66.77M | 117.25%24.04M | 36.72%7.08M | --3.47M | -75.54%12.79M | -78.15%11.07M |
| Cash outflows from financing activities | -17.33%677.47M | -23.39%526.93M | -29.28%395.3M | 1,771.15%92.46M | 148.50%819.48M | 110.60%687.82M | 3,819.02%559M | -45.62%4.94M | -20.97%329.77M | -21.36%326.6M |
| Net cash flows from financing activities | 93.42%-28.46M | 99.05%-3.26M | 96.62%-12.07M | 3,930.08%189.27M | -325.37%-432.19M | -57.55%-341.27M | -2,402.84%-357M | 45.62%-4.94M | 75.11%-101.6M | 46.69%-216.6M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -93.30%263.85K | -87.02%502.57K | -83.91%572.91K | -93.06%120.75K | -36.56%3.94M | -20.19%3.87M | 65.44%3.56M | 805.83%1.74M | 779.18%6.2M | 11,969.01%4.85M |
| Net increase in cash and cash equivalents | 6.28%-135.71M | 141.55%107.62M | 128.73%37.81M | 157.88%244.68M | 81.27%-144.81M | 65.17%-259.03M | 75.25%-131.59M | 143.76%94.88M | -715.64%-773.11M | -151.76%-743.65M |
| Add:Begin period cash and cash equivalents | -9.54%1.37B | -9.54%1.37B | -9.54%1.37B | -9.54%1.37B | -33.74%1.52B | -33.74%1.52B | -33.74%1.52B | -33.74%1.52B | -3.97%2.29B | -3.97%2.29B |
| End period cash equivalent | -9.88%1.24B | 17.62%1.48B | 1.77%1.41B | 0.31%1.62B | -9.54%1.37B | -18.64%1.26B | -21.20%1.39B | -22.24%1.61B | -33.74%1.52B | -25.97%1.55B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | -- | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.